Skip to content

Ceva CEVA Granted (in shares)

Granted (in shares) at other companies

Repligen logo
RepligenRGEN
$125.03
Genpact logo
GenpactG
$0.00
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$10.29
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$32.52
Wingstop logo
WingstopWING
$0.00
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$34.31+175%

Other financials

Income statement

See full
Revenue$27.0M+11.5%
Gross profit$23.3M+12.2%
Operating income-$5.1M-16.0%
Net income-$4.5M-34.0%
EPS (diluted)-$0.21-200%

Balance sheet

See full
Cash & equivalents$21.4M+13.6%
Total debt$16.9M+249%
Total equity$338.2M+25.7%
Total assets$388.2M+25.2%

Cash flow

See full
Operating cash flow-$4.9M+34.0%
CapEx$2.3M+644%
Free cash flow-$7.2M+6.7%

Valuation

See full
Market cap$1.25B+154%
Enterprise value$1.25B+161%
P/S11.2×+6.6×

Profitability

See full
Gross margin89.9%
Operating margin-0.3%
Net margin-10.5%+26.2pp
FCF margin1%

Returns & leverage

See full
Return on equity-3.9%+4.7pp
Debt / equity0.0×
Current ratio10.3×+2.8×

Where this comes from

Reported directly by Ceva in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: Ceva’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ceva's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ceva's granted (in shares)?
Ceva (CEVA) reported granted (in shares) of $0.00 in Q1 2026.
What does granted (in shares) mean?
The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.